Skip to main content

In Vitro Trapping and Screening of Reactive Metabolites Using Liquid Chromatography-Mass Spectrometry

  • Protocol
  • First Online:
Optimization in Drug Discovery

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

Abstract

Metabolism catalyzed by the cytochrome P450 enzymes (CYPs) represents the most important clearance pathways for most drugs in humans. However, CYP-mediated metabolism can also lead to drug bioactivation resulting to formation of reactive metabolites that can potentially induce idiosyncratic toxicity by covalently binding to endogenous proteins and nucleic acids. Therefore, it has become imperative to implement strategies for screening and identifying bioactivation liability of drug candidates as an integrated approach to reduce the attrition rate in drug discovery and development. This chapter describes a detailed protocol for the in-vitro stable isotopic trapping and screening for reactive metabolites using common LC-MS/MS methodologies such as neutral loss scan and precursor ion scan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ulrich RG (2007) Idiosyncratic toxicity: a convergence of risk factors. Annu Rev Med 58:17–34

    Article  PubMed  CAS  Google Scholar 

  2. Boelsterli UA (2003) Idiosyncratic drug hepatotoxicity revisited: new insights from mechanistic toxicology. Toxicol Mech Methods 13:3–20

    Article  PubMed  CAS  Google Scholar 

  3. Caldwell GW, Yan Z (2006) Screening for reactive intermediates and toxicity assessment in drug discovery. Curr Opin Drug Discov Devel 9:47–60

    PubMed  CAS  Google Scholar 

  4. Prakash C, Sharma R, Gleave M, Nedderman A (2008) In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery. Curr Drug Metab 9:952–964

    Article  PubMed  CAS  Google Scholar 

  5. Kalgutkar AS, Gardner I, Obach RS, Shaffer CL, Callegari E, Henne KR, Mutlib AE, Dalvie DK, Lee JS, Nakai Y et al (2005) A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 6:161–225

    Article  PubMed  CAS  Google Scholar 

  6. Yan Z, Maher N, Torres R, Huebert N (2007) Use of a trapping agent for simultaneous capturing and high-throughput screening of both “soft” and “hard” reactive metabolites. Anal Chem 79:4206–4214

    Article  PubMed  CAS  Google Scholar 

  7. Yan Z, Caldwell GW (2004) Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature. Anal Chem 76:6835–6847

    Article  PubMed  CAS  Google Scholar 

  8. Yan Z, Maher N, Torres R, Caldwell GW, Huebert N (2005) Rapid detection and characterization of minor reactive metabolites using stable-isotope trapping in combination with tandem mass spectrometry. Rapid Commun Mass Spectrom 19:3322–3330

    Article  PubMed  CAS  Google Scholar 

  9. Wen B, Ma L, Nelson SD, Zhu M (2008) High throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry. Anal Chem 80:1788–1799

    Article  PubMed  CAS  Google Scholar 

  10. Yan Z, Caldwell GW, Maher N (2008) Unbiased high-throughput screening of reactive metabolites on the linear ion trap mass spectrometer using polarity switch and mass tag triggered data-dependent acquisition. Anal Chem 80:6410–6422

    Article  PubMed  CAS  Google Scholar 

  11. Ma L, Wen B, Ruan Q, Zhu M (2008) Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining. Chem Res Toxicol 21:1477–1483

    Article  PubMed  CAS  Google Scholar 

  12. Liao S, Ewing NP, Boucher B, Materne O, Brummel CL (2012) High-throughput screening for glutathione conjugates using stable-isotope labeling and negative electrospray ionization precursor-ion mass spectrometry. Rapid Commun Mass Spectrom 26:659–669

    Article  PubMed  CAS  Google Scholar 

  13. Rousu T, Pelkonen O, Tolonen A (2009) Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 23:843–855

    Article  PubMed  CAS  Google Scholar 

  14. Jian W, Liu H-F, Zhao W, Jones E, Zhu M (2012) Simultaneous screening of glutathione and cyanide adducts using precursor ion and neutral loss scans-dependent product ion spectral acquisition and data mining tools. J Am Soc Mass Spectrom 23:964–976

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The views expressed here are solely those of the author and do not reflect the opinions of Janssen Research & Development, LLC.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Yan, Z., Caldwell, G.W. (2014). In Vitro Trapping and Screening of Reactive Metabolites Using Liquid Chromatography-Mass Spectrometry. In: Caldwell, G., Yan, Z. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-742-6_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-742-6_28

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-741-9

  • Online ISBN: 978-1-62703-742-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics